Journal Article

New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma

Zhao, Wenyue, Liu, Yang, Yang, Ying, Wang, Liming

2024

Overview

Background Lung adenocarcinoma (LUAD) is a non-small cell carcinoma. Ribonuclease/angiogenin inhibitor 1 (RNH1) exerts multiple roles in virous cancers. E2F1 is a critical transcription factor involved in the LUAD development. Here, we analyze the expression of RNH1 in LUAD patients, investigate the biological function of RNH1 in LUAD, and demonstrate its potential mechanisms through E2F1 in LUAD. Methods In the present study, we presented the expression of RNH1 in LUAD based on the database and confirmed it by western blot detection of RNH1 in human LUAD tissues. Lentiviral infection was constructed to silence or overexpress RNH1 in NCI-H1395 and NCI-H1437 cells. We assess the role of RNH1 on proliferation in LUAD cells by MTT assay, colony formation assays, and cell cycle detection. Hoechst staining and flow cytometry were used to evaluate the effects of RNH1 on apoptosis of LUAD cells. The function of RNH1 in invasion and migration was investigated by Transwell assay. Dual luciferase assay, ChIP detection, and pull-down assay were conducted to explore the association of E2F1 in the maintenance of RNH1 expression and function. The regulation of E2F1 on the functions of RNH1 in LUAD cells was explored. Mouse experiments were performed to confirm the in-vivo role of RNH1 in LUAD. mRNA sequencing indicated that RNH1 overexpression altered the expression profile of LUAD cells. Results RNH1 expression in LUAD tissues of patients was presented in this work. Importantly, RNH1 knockdown improved the proliferation, migration and invasion abilities of cells and RNH1 overexpression produced the opposite effects. Dual luciferase assay proved that E2F1 bound to the RNH1 promoter (-1064 ∼ -1054, -1514 ∼ -1504) to reduce the transcriptional activity of RNH1. ChIP assay indicated that E2F1 DNA was enriched at the RNH1 promoter (-1148 ∼ -943, -1628 ∼ -1423). Pull-down assays also showed the association between E2F1 and RNH1 promoter (-1148 ∼ -943). E2F1 overexpression contributed to the malignant behavior of LUAD cells, while RNH1 overexpression reversed it. High-throughput sequencing showed that RNH1 overexpression induced multiple genes expression changes, thereby modulating LUAD-related processes. Conclusion Our study demonstrates that binding of E2F1 to the RNH1 promoter may lead to inhibition of RNH1 expression and thus promoting the development of LUAD.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adenocarcinoma / Adenocarcinoma of Lung - genetics / Adenocarcinoma of Lung - metabolism / Adenocarcinoma of Lung - pathology / Analysis / Angiogenin / Animals / Antibodies / Apoptosis / Apoptosis - genetics / Biomedical and Life Sciences / Biomedicine / Cancer Research / Care and treatment / Cell cycle / Cell Line, Tumor / Cell Movement - genetics / Cell proliferation / Cell Proliferation - genetics / Cloning / Diagnosis / E2F transcription factor 1 (E2F1) / E2F1 Transcription Factor - genetics / E2F1 Transcription Factor - metabolism / Experiments / Female / Flow cytometry / Gastric cancer / Gene expression / Gene Expression Regulation, Neoplastic / Genetic aspects / Genetic transcription / Health Promotion and Disease Prevention / Humans / Laboratory animals / Lung adenocarcinoma / Lung cancer / Lung Neoplasms - genetics / Lung Neoplasms - metabolism / Lung Neoplasms - pathology / Male / Medicine/Public Health / Metastasis / Mice / Mice, Nude / Next-generation sequencing / Oncology / Proteins / Ribonuclease/angiogenin inhibitor 1 (RNH1) / RNA sequencing / Roles / Surgical Oncology / Transcription factors / Tumorigenesis / Tumors